Emergent BioSolutions Inc (NYSE:EBS)

79.16
Delayed Data
As of Nov 24
 -0.01 / -0.01%
Today’s Change
46.37
Today|||52-Week Range
137.61
+46.73%
Year-to-Date
2 Pick-and-Shovel COVID Vaccine Stocks to Watch
Nov 23 / MotleyFool.com - Paid Partner Content
Is Emergent BioSolutions (EBS) a Good Stock to Pick Now?
Nov 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close79.17
Today’s open80.50
Day’s range78.05 - 80.50
Volume673,685
Average volume (3 months)807,756
Market cap$4.3B
Data as of 4:00pm ET, 11/24/2020

Growth & Valuation

Earnings growth (last year)-15.45%
Earnings growth (this year)+143.81%
Earnings growth (next 5 years)+8.40%
Revenue growth (last year)+41.36%
P/E ratio25.4
Price/Sales2.56
Price/Book3.90

Competitors

 Today’s
change
Today’s
% change
ALLOAllogene Therapeutic...+0.51+1.67%
----
FATEFate Therapeutics In...+0.98+1.81%
TWSTTwist Bioscience Cor...-13.02-11.11%
Data as of 6:25pm ET, 11/24/2020

Financials

Next reporting dateFebruary 25, 2021
EPS forecast (this quarter)$2.90
Annual revenue (last year)$1.1B
Annual profit (last year)$54.5M
Net profit margin4.93%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts